Navigation Links
Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
Date:3/12/2008

22 29 90 108

Gross margin 245 88 490 600

Operating expenses:

Research and development 1,247 6,164 13,491 28,064

Selling, general and

administrative 3,995 6,040 16,865 25,152

Provision for settlement of

litigation (1,640) 5,280 (4,240) 5,280

Write-off of prepaid royalty - 1,268 - 1,268

Total operating expenses 3,602 18,752 26,116 59,764

Other income 139 431 836 1,454

Net loss before income tax benefit (3,218) (18,233) (24,790) (57,710)

Income tax benefit 1,470 929 1,470 929

Net loss $ (1,748) $(17,304) $(23,320) $(56,781)

Net loss per basic and diluted

share $ (0.06) $ (0.68) $ (0.79) $ (2.52)

Shares used in computing basic and

diluted net loss per share

(adjusted for 1-for-6 reverse

stock split on July 13, 2007) 30,621 25,621 29,621 22,553

Selected Condensed Consolidated Balance Sheet Data

(Unaudited)

December 31 December 31

2007 2006

Cash, cash equivalents and

marketable securities $ 7,813 $ 29,496

Working capital 877 12,682

Total assets 29,293 51,778

Total stockholders' equity 2,931 14,642


'/>"/>
SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
4. Genta Clinical Programs Featured at American Society of Hematology Meeting
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Genta Incorporated Announces Third Quarter 2007 Financial Results
7. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
8. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
11. Inclinix Announces New Patent for Expert System Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/d85hx9/global_rapid ) has announced the ... Market - Applications and Technologies" report to their ... Kits, estimated at US$19.4 billion in 2014, forecast at ... a CAGR of 5.7% between 2014 and 2020 to ... The global market for Rapid Medical Diagnostic Kits (MDKs) ...
(Date:5/27/2015)... , May 27, 2015  With Freudenberg ... a unique service: machined seals from the ... The seals, that have the same material ... original Freudenberg-NOK series products, can be made-to-order ... cost-effective small production runs. The agenda is ...
(Date:5/27/2015)... , LONDON and ... - http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html - Over ... - Around 400,000 Indonesians die annually due to ... - Three-fourths of 6.5 million vehicles in ... test Indonesia is ...
Breaking Medicine Technology:Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4Xpress Service from Freudenberg-NOK Quickly Delivers Made-to-Order Sealing Solutions to Customers 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 Dr. ... Institute based in Stamford, CT has been selected as ... the first physicians nationwide (and the only physician in ... injectable which allows for the removal of submental fat ... to no recovery time, no surgery and minimal risks. ...
(Date:5/27/2015)... Black Book Rankings, well known internationally ... multiple services and software industries, conducted a sweeping ... Electronic Health and Medical Record software systems for ... on implemented EHR users, Black Book reveals industry ... highest scores in client experience among small and ...
(Date:5/27/2015)... May 27, 2015 The Case ... a partnership to provide CMSA's Career and Knowledge ... collaboration seeks to strengthen the case/care management workforce ... CKP program. The mutually beneficial agreement provides Medix, ... skills of talent in the healthcare, scientific and ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
(Date:5/27/2015)... IL (PRWEB) May 27, 2015 On ... North-based advertising agency, will partner with LifeSource to host ... event will take place in a LifeSource donor coach ... a.m. to 4:00 p.m. , Demand for whole blood ... in Illinois, during the summer months. LifeSource requires approximately ...
Breaking Medicine News(10 mins):Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2
... Dec. 7 (HealthDay News) -- Positive family attitudes and ... reduce their risk of depression, substance abuse and suicidal ... finds. The study authors also found that those ... of self-esteem and social support when they,re young adults. ...
... a way to isolate neural stem cells cells that ... from human brain tissue with unprecedented precision, an important ... system, like Parkinson,s and Huntington,s diseases and spinal cord injury. ... the University of Rochester Medical Center was published in the ...
... public health concerns about increasing antiviral resistance among certain ... of alternative antiviral treatment options. The findings are published ... of Infectious Diseases . (Please see below for links ... with two classes of drugs: M2 blockers (adamantanes) and ...
... Randy Dotinga HealthDay Reporter , MONDAY, Dec. 6 (HealthDay ... an end to sex, according to an Australian study. The ... sexually active at least once a year -- including about 1 ... older men who are sexually active say they,d love to be ...
... of making, distributing and administering millions of seasonal ... design a vaccine that confers decades-long protection from ... influenza vaccine is feasible but licensing it may ... ways to evaluate the efficacy of vaccine candidates ...
... MONDAY, Dec. 6 (HealthDay News) -- A new study finds ... risk for high blood pressure, which is a major risk ... disease and stroke in the United States decreased 65 percent ... are still higher in the southeastern United States, in blacks ...
Cached Medicine News:Health News:Parents' Acceptance May Help Protect Gay Teens 2Health News:Stem cell advance a step forward for treatment of brain diseases 2Health News:Stem cell advance a step forward for treatment of brain diseases 3Health News:Influenza virus strains show increasing drug resistance and ability to spread 2Health News:Influenza virus strains show increasing drug resistance and ability to spread 3Health News:Many Men Over 75 Still Sexually Active: Study 2Health News:Many Men Over 75 Still Sexually Active: Study 3Health News:A flu vaccine that lasts 2Health News:Race, Gender Play Part in Hypertension Risk 2
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: